SCHEMBL19729664

SCHEMBL19729664

c1ccc(-c2ccc(-c3cccc(-c4ccccc4)c3-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4ccccc43)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK14 Q16539 1/20 0.38
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
XBP1 P17861 1/20 0.35
PTBP1 P26599 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
SMAD3 P84022 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19729679 0.93 KDM4E (0.43) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL19729685 0.89 TNF (0.40) ATML3MBTL1KDM4EMAPK14
SCHEMBL19729717 0.89 MAPK14 (0.38) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL21165618 0.88 ATM (0.50) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL19737821 0.87 PDK2 (0.33) MAPK14MEN1KMT2APRKDC
SCHEMBL19729680 0.87 PDK2 (0.33) MAPK14MEN1KMT2APRKDC
SCHEMBL19729705 0.86 MAPK14 (0.42) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL19075908 0.86 ALDH1A1 (0.44) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL20865082 0.86 ATM (0.46) ATML3MBTL1KDM4EMAPK14ALDH1A1
SCHEMBL21147184 0.85 KDM4E (0.37) ATML3MBTL1KDM4EMAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10957862-B2 Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-03-23 US disclosed
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-12-21 US disclosed
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ATM 1582/4885L3MBTL1 958/4885KDM4E 2960/4885
US-10957862-B2 Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound CRY1, CRY2, OCIAD1 ATM 1612/4885L3MBTL1 847/4885KDM4E 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.